Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]
Pharmaceutical Science Advances · 2026-12 · 4 · 100142
DOI: 10.1016/j.pscia.2026.100142 ↗Kurz gefasst
Korrektur in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Fei Teng und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, PR China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
[This corrects the article DOI: 10.1016/j.pscia.2025.100063.].
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, PR China.
Zitieren
APA
Teng, F., & Wang, H. (2026). Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]. Pharmaceutical Science Advances, 4, 100142. https://doi.org/10.1016/j.pscia.2026.100142
Vancouver
Teng F, Wang H. Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]. Pharmaceutical Science Advances. 2026;4:100142. doi:10.1016/j.pscia.2026.100142
BibTeX
@article{Teng2026,
author = {Teng, Fei and Wang, Haina},
title = {Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]},
journal = {Pharmaceutical Science Advances},
year = {2026},
volume = {4},
pages = {100142},
doi = {10.1016/j.pscia.2026.100142}
}
EUVIMED